Sun C, Chen Y, Guan Y, Zeng Y, Li J, Chen L
Front Nutr. 2025; 11:1461196.
PMID: 39925970
PMC: 11802416.
DOI: 10.3389/fnut.2024.1461196.
Saafi M, Ali K, Dhaoui R, Toumia M, Sassi S, Bendaya Y
Hypertens Res. 2024; 48(3):1135-1143.
PMID: 39695330
DOI: 10.1038/s41440-024-02018-6.
Govindasamy K, Kaur D, Elayaraja M, Sethi D, Kalidas S, Karmakar D
Ann Neurosci. 2024; :09727531241299258.
PMID: 39678718
PMC: 11638923.
DOI: 10.1177/09727531241299258.
Bressman E, Profka K, Norton L, Clark K, Mahraj K, Walker Z
J Gen Intern Med. 2024; .
PMID: 39633105
DOI: 10.1007/s11606-024-09225-4.
Wang Y, Hu Z, Ding Y, Sun Y, Meng R, He Y
J Multidiscip Healthc. 2024; 17:4319-4334.
PMID: 39246561
PMC: 11380850.
DOI: 10.2147/JMDH.S481425.
Association of the weight-adjusted waist index with hypertension in the context of predictive, preventive, and personalized medicine.
Sun Q, Yang Y, Liu J, Ye F, Hui Q, Chen Y
EPMA J. 2024; 15(3):491-500.
PMID: 39239106
PMC: 11371960.
DOI: 10.1007/s13167-024-00375-3.
The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study.
Molavizadeh D, Cheraghloo N, Tohidi M, Azizi F, Hadaegh F
Cardiovasc Diabetol. 2024; 23(1):321.
PMID: 39217401
PMC: 11365227.
DOI: 10.1186/s12933-024-02387-9.
Global prevalence and disability-adjusted life years of hypertensive heart disease: A trend analysis from the Global Burden of Disease Study 2019.
Liu A, Lin Y, Meng T, Tian P, Chen J, Zhang X
J Glob Health. 2024; 14:04172.
PMID: 39212657
PMC: 11364089.
DOI: 10.7189/jogh.14.04172.
Impact of hypertensive heart disease, risk factors, and age-period-cohort models across 204 nations and regions from 1990 to 2019: a global perspective from the 2019 global burden of disease study.
Gao G, Chen Z, Yan G, Bao M
Front Cardiovasc Med. 2024; 11:1417523.
PMID: 39091356
PMC: 11291211.
DOI: 10.3389/fcvm.2024.1417523.
Obstructive Sleep Apnea and Hypertensive Heart Disease: From Pathophysiology to Therapeutics.
Liu L, Wang Y, Hong L, Bragazzi N, Dai H, Chen H
Rev Cardiovasc Med. 2024; 24(12):342.
PMID: 39077075
PMC: 11272867.
DOI: 10.31083/j.rcm2412342.
Two-Drug Combinations Therapy of Different Doses of Valsartan Existing Diverse Significance for Hypertensive Patients.
Wang Z, Wang S, Zhang L, Wang J, Wang R, Chen S
Rev Cardiovasc Med. 2024; 24(7):187.
PMID: 39077003
PMC: 11266496.
DOI: 10.31083/j.rcm2407187.
Hypertension and Heart Failure: From Pathophysiology to Treatment.
Gallo G, Savoia C
Int J Mol Sci. 2024; 25(12).
PMID: 38928371
PMC: 11203528.
DOI: 10.3390/ijms25126661.
A study on the application of radiomics based on cardiac MR non-enhanced cine sequence in the early diagnosis of hypertensive heart disease.
Ma Z, Wang S, Xue L, Zhang X, Zheng W, Zhao Y
BMC Med Imaging. 2024; 24(1):124.
PMID: 38802736
PMC: 11129462.
DOI: 10.1186/s12880-024-01301-9.
Association of hypertension and depression with mortality: an exploratory study with interaction and mediation models.
Huang H, Meng F, Qi Y, Yan X, Qi J, Wu Y
BMC Public Health. 2024; 24(1):1068.
PMID: 38632586
PMC: 11022319.
DOI: 10.1186/s12889-024-18548-0.
Unique characteristics of Asians with hypertension: what is known and what can be done?.
Loo G, Puar T, Foo R, Ong T, Wang T, Nguyen Q
J Hypertens. 2024; 42(9):1482-1489.
PMID: 38509747
PMC: 11296281.
DOI: 10.1097/HJH.0000000000003706.
Identification of Circulating Plasma Proteins as a Mediator of Hypertension-Driven Cardiac Remodeling: A Mediation Mendelian Randomization Study.
Hu Y, Lin L, Zhang L, Li Y, Cui X, Lu M
Hypertension. 2024; 81(5):1132-1144.
PMID: 38487880
PMC: 11025611.
DOI: 10.1161/HYPERTENSIONAHA.123.22504.
Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension.
Chu H, Hwang I, Kim H, Park J, Choi H, Choi H
Hypertens Res. 2024; 47(5):1144-1156.
PMID: 38238511
DOI: 10.1038/s41440-023-01571-w.
Global, regional, and national burdens of hypertensive heart disease from 1990 to 2019 ：A multilevel analysis based on the global burden of Disease Study 2019.
Hu B, Shi Y, Zhang P, Fan Y, Feng J, Hou L
Heliyon. 2024; 9(12):e22671.
PMID: 38213586
PMC: 10782162.
DOI: 10.1016/j.heliyon.2023.e22671.
Persistence of severe global inequalities in the burden of Hypertension Heart Disease from 1990 to 2019: findings from the global burden of disease study 2019.
Lu M, Li D, Hu Y, Zhang L, Li Y, Zhang Z
BMC Public Health. 2024; 24(1):110.
PMID: 38184560
PMC: 10771693.
DOI: 10.1186/s12889-023-17573-9.
miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathway.
Cai S, Chang J, Su M, Wei Y, Sun H, Chen C
Cell Mol Life Sci. 2023; 80(12):359.
PMID: 37951845
PMC: 10640488.
DOI: 10.1007/s00018-023-04987-2.
